You have 9 free searches left this month | for more free features.

Lupus Erythematosus, Cutaneous

Showing 1 - 25 of 3,248

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Lupus Erythematosus, Cutaneous, Subacute, Chronic Cutaneous Lupus Erythematosus Trial (BIIB059 (litifilimab))

Not yet recruiting
  • Lupus Erythematosus, Cutaneous, Subacute
  • Chronic Cutaneous Lupus Erythematosus
  • BIIB059 (litifilimab)
  • (no location specified)
Sep 12, 2023

Cutaneous Lupus Erythematosus Trial (Anifrolumab, Placebo)

Not yet recruiting
  • Cutaneous Lupus Erythematosus
  • Anifrolumab
  • Placebo
  • (no location specified)
Aug 22, 2023

Lupus Erythematosus, Systemic, Lupus Erythematosus, Cutaneous Trial (Placebo, PF-06823859)

Not yet recruiting
  • Lupus Erythematosus, Systemic
  • Lupus Erythematosus, Cutaneous
  • (no location specified)
May 18, 2023

Systemic Lupus Erythematosus, Cutaneous Lupus Erythematosus Trial (DS-7011a, Placebo)

Not yet recruiting
  • Systemic Lupus Erythematosus
  • Cutaneous Lupus Erythematosus
  • (no location specified)
Dec 12, 2022

Cutaneous Lupus Erythematosus (CLE) Trial (GS-5718, GS-5718 Placebo)

Not yet recruiting
  • Cutaneous Lupus Erythematosus (CLE)
  • (no location specified)
Dec 6, 2022

Cutaneous Lupus Erythematosus Trial in Dallas (UVA1 radiation treatment)

Completed
  • Cutaneous Lupus Erythematosus
  • UVA1 radiation treatment
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Nov 30, 2022

Cutaneous Lupus Erythematosus Trial in United States (GS-5718, Placebo)

Terminated
  • Cutaneous Lupus Erythematosus
  • Beverly Hills, California
  • +4 more
Nov 17, 2022

Healthy Volunteers, Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE) Trial in Sumida-ku (Placebo, KK4277)

Not yet recruiting
  • Healthy Volunteers
  • +2 more
  • Sumida-ku, Tokyo, Japan
    Medical Co. LTA Sumida Hospital
Jun 6, 2022

Clinical Severity of Cutaneous Lupus Erythematosus

Recruiting
  • Cutaneous Lupus Erythematosus (CLE)
    • Philadelphia, Pennsylvania
    • +1 more
    Jan 29, 2022

    Duke Lupus Registry

    Recruiting
    • Systemic Lupus Erythematosus
    • Cutaneous Lupus
      • Durham, North Carolina
        Duke University Medical Center
      Dec 19, 2022

      Cutaneous Lupus Registry

      Recruiting
      • Lupus Erythematosus
        • Dallas, Texas
          University of Texas Southwestern Medical Center Dallas
        Nov 2, 2022

        Lupus Erythematosus, Cutaneous Trial in Bern (Er:YAG laser)

        Withdrawn
        • Lupus Erythematosus, Cutaneous
        • Er:YAG laser
        • Bern, Switzerland
          Department of dermatology, University Hospital Inselspital, Bern
        Sep 13, 2021

        Systemic Lupus Erythematosus, Cutaneous Lupus Erythematosus Trial in Worldwide (M5049, Placebo)

        Recruiting
        • Systemic Lupus Erythematosus
        • Cutaneous Lupus Erythematosus
        • Pleven, Bulgaria
        • +10 more
        Jul 18, 2022

        Lupus Erythematosus, Discoid, Lupus Erythematosus, Subacute Cutaneous Trial in Worldwide (Deucravacitinib, Placebo)

        Recruiting
        • Lupus Erythematosus, Discoid
        • Lupus Erythematosus, Subacute Cutaneous
        • Los Angeles, California
        • +42 more
        Oct 21, 2022

        Lupus Erythematosus, Cutaneous, Lupus Erythematosus, Discoid, Lupus Erythematosus, Systemic Trial in West Hollywood

        Completed
        • Lupus Erythematosus, Cutaneous
        • +4 more
        • West Hollywood, California
          Cedars Sinai Medical Center-Wallace Rheumatic Study Center
        Aug 12, 2021

        Systemic Lupus Erythematosus, Cutaneous Lupus Trial in Ann Arbor (Tofacitinib)

        Recruiting
        • Systemic Lupus Erythematosus
        • Cutaneous Lupus
        • Ann Arbor, Michigan
          University of Michigan Health System: Department of Internal Med
        May 2, 2022

        Cutaneous Lupus, Systemic Lupus Erythematosus Trial in Cincinnati, Cleveland (Tofacitinib)

        Completed
        • Cutaneous Lupus
        • Systemic Lupus Erythematosus
        • Cincinnati, Ohio
        • +1 more
        Dec 19, 2022

        Lupus Erythematosus, Cutaneous Trial in Germany (GSK2646264 1%, Placebo)

        Completed
        • Lupus Erythematosus, Cutaneous
        • GSK2646264 1%
        • Placebo
        • Tuebingen, Baden-Wuerttemberg, Germany
        • +4 more
        Mar 11, 2021

        Lupus Trial in Worldwide (BMS-986326, Placebo for BMS-986326)

        Not yet recruiting
        • Lupus
        • Tampa, Florida
        • +10 more
        Aug 23, 2023

        Cutaneous Lupus Erythematosus, Systemic Lupus Erythematosus Rash Trial in Changsha (nicotinamide)

        Unknown status
        • Cutaneous Lupus Erythematosus
        • Systemic Lupus Erythematosus Rash
        • Changsha, Hunan, China
          The Second Xiangya Hospital of Central South University
        Jan 31, 2021

        Cutaneous Lupus Erythematosus Trial in Worldwide (SAR443122, Placebo)

        Recruiting
        • Cutaneous Lupus Erythematosus
        • Thousand Oaks, California
        • +54 more
        Aug 1, 2022

        Autoimmune Diseases, Pregnancy Related, Systemic Lupus Erythematosus Trial in Durham

        Recruiting
        • Autoimmune Diseases
        • +6 more
          • Durham, North Carolina
            Duke University
          Feb 8, 2022

          Lupus Erythematosus, Photosensitivity Conditions Trial in Philadelphia (Phototesting)

          Completed
          • Lupus Erythematosus
          • Photosensitivity Conditions
          • Phototesting
          • Philadelphia, Pennsylvania
            University of Pennsylvania
          Jul 12, 2021

          Discoid Lupus Erythematosus Trial in Cairo (Nicotinamide Topical)

          Completed
          • Discoid Lupus Erythematosus
          • Nicotinamide Topical
          • Cairo, Egypt
            AL-Azhar University Hospital
          Oct 22, 2022

          Systemic Lupus Erythematosus Trial (GLPG3667, Placebo)

          Not yet recruiting
          • Systemic Lupus Erythematosus
          • (no location specified)
          May 4, 2023